Literature DB >> 9713496

Parallel functional and immunological detection of human multidrug resistance proteins, P-glycoprotein and MRP1.

Z Holló1, L Homolya, T Hegedûs, M Müller, G Szakács, K Jakab, F Antal, B Sarkadi.   

Abstract

The proper assessment of the expression and drug extrusion activity of multidrug resistance proteins in various tumor cells is a challenging clinical laboratory problem. Recently, we have introduced a fluorescent dye (calcein) accumulation assay for the estimation of the functional expression of both P-glycoprotein (MDR1) and the multidrug resistance-associated protein (MRP1). Since both MDR1 and MRP1 decrease the intracellular accumulation of the fluorescent free calcein, by applying appropriate inhibitors of MDR1 and MRP1, the transport activity of these proteins could be quantitatively and selectively estimated in fluorometry or flow-cytometry assays. In the present work single-cell fluorescence digital imaging has been applied to characterize the kinetics and inhibitor-sensitivity of calcein accumulation in a mixture of HL60 MRP1 and NIH 3T3 MDR1 cells. Subsequent immunofluorescence labeling was performed by the anti-MDR1 monoclonal antibody (mAb) UIC2 in the same cell population. We report that the double labeling approach, based on the single cell calcein accumulation assay and an immunofluorescence detection, provides good sensitivity and selectivity for the simultaneous functional and immunological detection of cellular MDR1 and MRP1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9713496

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

Review 1.  The controversial role of ABC transporters in clinical oncology.

Authors:  Akina Tamaki; Caterina Ierano; Gergely Szakacs; Robert W Robey; Susan E Bates
Journal:  Essays Biochem       Date:  2011-09-07       Impact factor: 8.000

Review 2.  Diagnostics of multidrug resistance in cancer.

Authors:  G Szakács; K Jakab; F Antal; B Sarkadi
Journal:  Pathol Oncol Res       Date:  1998       Impact factor: 3.201

3.  St. John's Wort constituents modulate P-glycoprotein transport activity at the blood-brain barrier.

Authors:  Melanie Ott; Miriam Huls; Michael G Cornelius; Gert Fricker
Journal:  Pharm Res       Date:  2010-03-13       Impact factor: 4.200

4.  Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation.

Authors:  U Andersson; K Grankvist; A T Bergenheim; P Behnam-Motlagh; H Hedman; R Henriksson
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

Review 5.  Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance.

Authors:  Gergely Szakács; Matthew D Hall; Michael M Gottesman; Ahcène Boumendjel; Remy Kachadourian; Brian J Day; Hélène Baubichon-Cortay; Attilio Di Pietro
Journal:  Chem Rev       Date:  2014-04-23       Impact factor: 60.622

6.  Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters.

Authors:  Ágnes Telbisz; Csilla Ambrus; Orsolya Mózner; Edit Szabó; György Várady; Éva Bakos; Balázs Sarkadi; Csilla Özvegy-Laczka
Journal:  Pharmaceutics       Date:  2021-01-09       Impact factor: 6.321

7.  P-Glycoprotein Activity at Diagnosis Does Not Predict Therapy Outcome and Survival in Canine B-Cell Lymphoma.

Authors:  Valéria Dékay; Edina Karai; András Füredi; Kornélia Szebényi; Gergely Szakács; Péter Vajdovich
Journal:  Cancers (Basel)       Date:  2022-08-13       Impact factor: 6.575

8.  A new fluorescent dye accumulation assay for parallel measurements of the ABCG2, ABCB1 and ABCC1 multidrug transporter functions.

Authors:  Edit Szabó; Dóra Türk; Ágnes Telbisz; Nóra Kucsma; Tamás Horváth; Gergely Szakács; László Homolya; Balázs Sarkadi; György Várady
Journal:  PLoS One       Date:  2018-01-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.